72 related articles for article (PubMed ID: 351953)
21. Immune monitoring of cancer patients undergoing experimental immunotherapy.
Shankar G; Salgaller ML
Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of leukocyte migration by tumor-associated antigen and its modification by serum; IgA as a blocking factor.
Sipos J; Gábor V; Tóth Z
Neoplasma; 1978; 25(2):181-8. PubMed ID: 643122
[TBL] [Abstract][Full Text] [Related]
23. [Suppression of leukocyte migration in bladder cancer with tumor antigens before and after surgery].
Borisenko ID; Novikov DK; Shein IA
Urol Nefrol (Mosk); 1978; (2):26-9. PubMed ID: 644715
[No Abstract] [Full Text] [Related]
24. [Determination of leukocyte sensitization to tumor and embryonic tissue antigens in cancer of the large intestine].
Novikov DK; Shmakov AP
Vopr Onkol; 1981; 27(8):40-5. PubMed ID: 6269300
[TBL] [Abstract][Full Text] [Related]
25. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
Urist MM; Boddie AW; Townsend CM; Holmes EC
J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
[TBL] [Abstract][Full Text] [Related]
26. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
Nakamura S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
[TBL] [Abstract][Full Text] [Related]
27. [Effect of tumor antigens on leukocyte adherence in the blood in stomach cancer].
Zharkov VV; Novikov DK
Vopr Onkol; 1983; 29(2):14-8. PubMed ID: 6836968
[TBL] [Abstract][Full Text] [Related]
28. Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects.
Adler A; Gillon G; Lurie H; Shaham J; Loven D; Shachter Y; Shani A; Servadio C; Stein JA
J Biol Response Mod; 1987 Dec; 6(6):610-24. PubMed ID: 3330126
[TBL] [Abstract][Full Text] [Related]
29. T-cell distribution and adhesion receptor expression in metastatic melanoma.
Weishaupt C; Munoz KN; Buzney E; Kupper TS; Fuhlbrigge RC
Clin Cancer Res; 2007 May; 13(9):2549-56. PubMed ID: 17473183
[TBL] [Abstract][Full Text] [Related]
30. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
31. Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.
Noonan FP; Halliday WJ; Wall DR; Clunie GJ
Cancer Res; 1977 Aug; 37(8 Pt 1):2473-80. PubMed ID: 872076
[TBL] [Abstract][Full Text] [Related]
32. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
33. [Specific cellular immunity indices in acute leukemia in children].
Osipov SG; Bergol'ts VM; Eremeev VS; Akimova GV; Rumiantsev AG
Vopr Onkol; 1981; 27(1):20-2. PubMed ID: 7456440
[TBL] [Abstract][Full Text] [Related]
34. Reactivity in neoplasia, preneoplasia, and pregnancy of lymphocytes against fetal extracts: cross-reactions between man and mouse.
Pasternak G; Schlott B; Reinhöfer J; Gryschek G; von Broen B; Albrecht S
J Natl Cancer Inst; 1982 Nov; 69(5):997-1004. PubMed ID: 6957663
[TBL] [Abstract][Full Text] [Related]
35. Leukocyte migration inhibition in vitro in untreated and methimazole-treated patients with Graves disease.
Kálmán K; Fazakas S; Erdei I; Leövey A
Acta Med Acad Sci Hung; 1976; 33(4):327-32. PubMed ID: 1037636
[TBL] [Abstract][Full Text] [Related]
36. [Effect of serum fractions from cancer patients on leukocyte migration out of capillary tubes].
Novikov DK; Shmakov AP; Borisenko ID
Biull Eksp Biol Med; 1978 Nov; 86(11):568-72. PubMed ID: 363203
[TBL] [Abstract][Full Text] [Related]
37. Common aspects of immunologic tolerance in pregnancy and malignancy.
Gleicher N; Deppe G; Cohen CJ
Obstet Gynecol; 1979 Sep; 54(3):335-42. PubMed ID: 382002
[TBL] [Abstract][Full Text] [Related]
38. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
[TBL] [Abstract][Full Text] [Related]
39. Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
Tosner J; Fixa B
Clin Exp Immunol; 1979 Nov; 38(2):356-60. PubMed ID: 527267
[TBL] [Abstract][Full Text] [Related]
40. [Stimulation of cellular immunity in patients with malignant tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA; Vostrikova NA
Vopr Onkol; 1973; 19(12):30-4. PubMed ID: 4544936
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
